Efficacy and Safety of Irinotecan Liposome Injection Combined With 5-FU/LV± Immunotherapy in First-line Gemsitabine + Immunoprogressive Patients With Metastatic Biliary Tract Cancer
Clinical trial NCT06282120 · UNKNOWN
Trial details
- NCT number
- NCT06282120
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-01-01
- Primary completion
- 2025-01-05
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.